Archives

GLP-1 Drugs Linked With Chronic Cough

People with type 2 diabetes taking glucagon-like peptide-1 (GLP-1) receptor agonists were more likely to develop chronic cough than people using other second-line medications, a new study found.

The Century of History Shaping the Debate Over GLP-1s

The debate over whether insurers should pay for GLP-1 drugs like Ozempic and Wegovy has revived a familiar American argument about why people get sick. Some commentators have insisted that the powerful weight-loss drugs are “shortcuts” for people unwilling to exercise greater self-control, a concern echoed in coverage noting that experts worry too many patients […]

Novo Nordisk Files NDA for Next-Generation Obesity Drug CagriSema

Novo Nordisk NVO announced the submission of a new drug application (NDA) to the FDA, seeking approval for its next-generation once-weekly injection, CagriSema, to reduce excess body weight and maintain weight reduction in the long term in adults with obesity or overweight. The FDA is expected to review the application in 2026. The candidate is intended […]

Did Eli Lilly Just Find the Holy Grail of Weight Loss?

Quick Read Eli Lilly (LLY) submitted an FDA application for orforglipron. The once-daily oral pill maintained weight loss after patients switched from injections. Lilly’s Zepbound achieved 20.2% average weight loss over 72 weeks versus 13.7% for Novo Nordisk‘s Wegovy in a Phase 3 trial. Novo Nordisk’s higher-dose oral semaglutide could be approved by year-end. Lilly’s […]

Lawsuits Allege Ozempic Is Causing Blindness

Ozempic and similar weight loss drugs have been found to cut risks for a variety of health issues — ranging from heart to kidney disease — netting the pharma companies behind them billions of projected dollars in revenue over the next decade. But in rare cases, this class of drugs called GLP-1 agonists can come […]

GLP-1 pills are on the way. Here’s what to know : Short Wave – NPR

GLP-1 pills are on the way. Here’s what to know : Short Wave  NPR Wegovy Maker Novo Nordisk Files for FDA Approval of Obesity Drug CagriSema  The Wall Street Journal Eli Lilly, Novo Nordisk file new weight-loss drugs that could be game changers in obesity medicine  MarketWatch Novo files marketing application for next-gen weight-loss drug  Reuters Healthy Returns: 2026 […]

IJMS, Vol. 27, Pages 27: The Roles of Incretin Hormones GIP and GLP-1 in Metabolic and Cardiovascular Health: A Comprehensive Review

IJMS, Vol. 27, Pages 27: The Roles of Incretin Hormones GIP and GLP-1 in Metabolic and Cardiovascular Health: A Comprehensive Review International Journal of Molecular Sciences doi: 10.3390/ijms27010027 Authors: Dai Yamanouchi The incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) play central roles in metabolic and cardiovascular regulation. GLP-1 receptor agonists (GLP-1RAs) are […]